[ad_1] Molecular Targeting Technologies, Inc. and Molecular Theranostics … WV News [ad_2] Source link
Tag: HSA
Everest Medicines Announces New Drug Application Acceptance by Singapore HSA for Nefecon for the Treatment of Primary IgA Nephropathy
[ad_1] Nefecon NDA is currently under Priority Review in China and expected to receive approval in 2H 2023 SHANGHAI, April 5, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or…